We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

84 hedge funds and large institutions have $61.1M invested in Aldeyra Therapeutics in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

354% more call options, than puts

Call options by funds: $454K | Put options by funds: $100K

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

67% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 18

47% more capital invested

Capital invested by funds: $41.4M → $61.1M (+$19.7M)

17% more funds holding

Funds holding: 72 → 84 (+12)

7.38% less ownership

Funds ownership: 56.55% → 49.17% (-7.4%)

27% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 26

Holders
84
Holders Change
+12
Holders Change %
+16.67%
% of All Funds
1.72%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
30
Increased
19
Reduced
26
Closed
18
Calls
$454K
Puts
$100K
Net Calls
+$354K
Net Calls Change
+$366K

Top Buyers

1
GTC
Ghost Tree Capital
New York
+$3.65M
2
ACP
Acuta Capital Partners
California
+$3.25M
3
BBVA
Banco Bilbao Vizcaya Argentaria
Spain
+$964K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$950K
5
Morgan Stanley
Morgan Stanley
New York
+$789K

Top Sellers

1
BlackRock
BlackRock
New York
-$4.13M
2
6CM
683 Capital Management
New York
-$2.78M
3
SFM
Sphera Funds Management
Israel
-$2.64M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.17M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$12.9M – – –
PM
2
Prosight Management
Texas
$6.76M -$1.52M -415,140 -20%
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.31M -$342K -93,671 -8%
GTC
4
Ghost Tree Capital
New York
$4.17M +$3.65M +1,000,000 New
ACP
5
Acuta Capital Partners
California
$3.71M +$3.25M +890,000 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$2.55M -$2.17M -594,600 -49%
JJIJ
7
Johnson & Johnson Innovation - JJDC
New Jersey
$2.48M – – –
KCM
8
Knoll Capital Management
Florida
$2.37M – – –
Millennium Management
9
Millennium Management
New York
$2.37M -$920K -251,930 -31%
BlackRock
10
BlackRock
New York
$2.02M -$4.13M -1,130,619 -70%
BBVA
11
Banco Bilbao Vizcaya Argentaria
Spain
$1.31M +$964K +263,889 +528%
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$1.27M +$950K +260,076 +578%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$999K -$340K -93,156 -28%
Morgan Stanley
14
Morgan Stanley
New York
$908K +$789K +215,879 +11,440%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$874K +$53.5K +14,650 +8%
Two Sigma Investments
16
Two Sigma Investments
New York
$724K +$348K +95,173 +121%
6CM
17
683 Capital Management
New York
$688K -$2.78M -760,000 -82%
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$665K +$462K +126,347 +382%
WC
19
Woodstock Corp
Massachusetts
$617K +$52.2K +14,286 +11%
Squarepoint
20
Squarepoint
New York
$608K +$421K +115,182 +378%
SSA
21
Schonfeld Strategic Advisors
New York
$574K +$503K +137,600 New
Jane Street
22
Jane Street
New York
$549K +$481K +131,590 New
PP
23
Paloma Partners
Connecticut
$512K +$449K +122,947 New
WMSA
24
Weiss Multi-Strategy Advisers
New York
$482K -$115K -31,563 -21%
Stifel Financial
25
Stifel Financial
Missouri
$477K +$165K +45,163 +65%
1
2 3 4

ALDX Hedge Fund Activity: Q2 2020 in Review

84 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q2 2020, worth a combined $61.1M — up 47% from $41.4M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ALDX positions and 18 closed out — a net gain of 12 holders — while 19 added to existing stakes and 26 trimmed.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.65M. The largest seller was BlackRock, cutting an estimated $4.13M.

  • 84 institutional investors held Aldeyra Therapeutics (ALDX) as of Q2 2020, up from 72 in Q1 2020.
  • Funds reported $61.1M of Aldeyra Therapeutics stock for Q2 2020, up 47% quarter-over-quarter.
  • 30 funds opened new Aldeyra Therapeutics positions in Q2 2020 and 18 closed out, a net change of +12 holders.
  • The largest Aldeyra Therapeutics buyer in Q2 2020 was Ghost Tree Capital, an estimated $3.65M added.
  • The largest Aldeyra Therapeutics seller in Q2 2020 was BlackRock, an estimated $4.13M sold.

Based on aggregated 13F filings for Q2 2020.